Wednesday 25 November 2015

Buy Morepen Laboratories Ltd. CMPrice. 28.35 Target 500 in two Year

Morepen Laboratories Ltd., incorporated in the year 1984, is a Mid Cap company (having a market cap of Rs 1275.26 Cr.) operating in Pharmaceuticals and health care sector.
Morepen Laboratories Ltd. key Products/Revenue Segments include API Chemicals which contributed Rs 216.06 Cr to Sales Value (58.35% of Total Sales), Tablets which contributed Rs 52.30 Cr to Sales Value (14.12% of Total Sales), Home Care which contributed Rs 51.31 Cr to Sales Value (13.85% of Total Sales), Syrups which contributed Rs 14.47 Cr to Sales Value (3.90% of Total Sales), Other Operating Revenue which contributed Rs 12.00 Cr to Sales Value (3.24% of Total Sales), Others which contributed Rs 10.88 Cr to Sales Value (2.93% of Total Sales),

Saturday 7 November 2015

Buy Maxwell Industries Ltd CMPrice. 51.80 Target 84 one Year

Buy Maxwell Industries Ltd. Rco Price. 51.80 Target 84 one Year

Maxwell Industries Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 342.94 Cr.) operating in Textiles sector.
Maxwell Industries Ltd. key Products/Revenue Segments include Knitwear which contributed Rs 252.57 Cr to Sales Value (96.73% of Total Sales), Others which contributed Rs 6.61 Cr to Sales Value (2.53% of Total Sales), Duty Drawback which contributed Rs 1.39 Cr to Sales

Sunday 25 October 2015

Buy Alembic Pharmaceuticals Target 930

Buy Alembic Pharmaceuticals Target 930 two Month.
Alembic Pharmaceuticals Ltd., incorporated in the year 2010, is a Large Cap company (having a market cap of Rs 13111.28 Cr.) operating in Pharmaceuticals and health care sector.
Alembic Pharmaceuticals Ltd. key Products/Revenue Segments include Tablets & Capsules which contributed Rs 1202.25 Cr to Sales Value (59.10% of Total Sales), Bulk Drugs Intermediates And Chemicals which contributed Rs 360.65 Cr to Sales Value (17.73% of Total Sales), Oral Preparations & Ointments which contributed Rs 350.35 Cr to Sales Value (17.22% of Total Sales), Injectables which contributed Rs 82.74 Cr to Sales Value (4.06% of Total Sales), Royalty Income which contributed Rs 19.97 Cr to